Wells Fargo’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-119,663
| Closed | -$19.8M | – | 7955 |
|
|
2021
Q2 | $19.8M | Sell |
119,663
-297,191
| -71% | -$49.6M | ﹤0.01% | 1687 |
|
|
2021
Q1 | $63.9M | Buy |
416,854
+99,966
| +32% | +$13.6M | 0.01% | 917 |
|
|
2020
Q4 | $39.8M | Sell |
316,888
-16,717
| -5% | -$1.87M | 0.01% | 1114 |
|
|
2020
Q3 | $33.8M | Sell |
333,605
-28,616
| -8% | -$2.92M | 0.01% | 1071 |
|
|
2020
Q2 | $35.2M | Sell |
362,221
-31,545
| -8% | -$2.94M | 0.01% | 1039 |
|
|
2020
Q1 | $32.7M | Sell |
393,766
-29,688
| -7% | -$2.9M | 0.01% | 973 |
|
|
2019
Q4 | $47.1M | Sell |
423,454
-4,274
| -1% | -$440K | 0.01% | 962 |
|
|
2019
Q3 | $42.4M | Sell |
427,728
-4,245
| -1% | -$422K | 0.01% | 994 |
|
|
2019
Q2 | $42.8M | Sell |
431,973
-481,708
| -53% | -$46M | 0.01% | 998 |
|
|
2019
Q1 | $101M | Buy |
913,681
+46,529
| +5% | +$4.86M | 0.03% | 552 |
|
|
2018
Q4 | $79.7M | Sell |
867,152
-21,295
| -2% | -$2.15M | 0.03% | 610 |
|
|
2018
Q3 | $97.9M | Sell |
888,447
-88,083
| -9% | -$9.17M | 0.03% | 597 |
|
|
2018
Q2 | $91.2M | Sell |
976,530
-71,751
| -7% | -$6.18M | 0.03% | 605 |
|
|
2018
Q1 | $87M | Buy |
1,048,281
+106,456
| +11% | +$9.46M | 0.03% | 628 |
|
|
2017
Q4 | $85.8M | Sell |
941,825
-265,244
| -22% | -$22.1M | 0.02% | 634 |
|
|
2017
Q3 | $91.9M | Buy |
1,207,069
+432,449
| +56% | +$32.7M | 0.03% | 593 |
|
|
2017
Q2 | $58.1M | Buy |
774,620
+165,105
| +27% | +$11.4M | 0.02% | 795 |
|
|
2017
Q1 | $39.8M | Buy |
609,515
+464,931
| +322% | +$27.4M | 0.01% | 972 |
|
|
2016
Q4 | $7.97M | Buy |
144,584
+42,313
| +41% | +$2.32M | ﹤0.01% | 2034 |
|
|
2016
Q3 | $5.78M | Buy |
102,271
+43,088
| +73% | +$2.11M | ﹤0.01% | 2174 |
|
|
2016
Q2 | $2.47M | Buy |
59,183
+13,038
| +28% | +$601K | ﹤0.01% | 2821 |
|
|
2016
Q1 | $1.97M | Sell |
46,145
-5,623
| -11% | -$238K | ﹤0.01% | 2929 |
|
|
2015
Q4 | $2.34M | Sell |
51,768
-15,542
| -23% | -$653K | ﹤0.01% | 2872 |
|
|
2015
Q3 | $2.61M | Buy |
67,310
+4,399
| +7% | +$176K | ﹤0.01% | 2794 |
|
|
2015
Q2 | $2.29M | Buy |
62,911
+36,797
| +141% | +$1.16M | ﹤0.01% | 2994 |
|
|
2015
Q1 | $753K | Buy |
26,114
+19,330
| +285% | +$539K | ﹤0.01% | 3704 |
|
|
2014
Q4 | $165K | Buy |
+6,784
| New | +$153K | ﹤0.01% | 4525 |
|
Other funds holding PRAH
Wells Fargo's PRAH Position: Q3 2021 in Review
Wells Fargo sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 119,663 shares — an estimated $19.8M sold.
Wells Fargo first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $101M in Q1 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Wells Fargo reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Wells Fargo sold 119,663 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $19.8M.
- Wells Fargo first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Wells Fargo's PRA Health Sciences, Inc. position peaked at $101M in Q1 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.